Our regression results indicate that the f-Hb threshold of 120 μg/g used in the NHS BCSP in England is likely to miss just over half of the CRC (51.1%) present at the time of sampling (Table 5). This evidence concerns the gene GSTM1 and colorectal carcinoma.